Skip to main content
Psychopharmacology Bulletin All Volumes & Issues VOL 51 No. 1
PSYCHOPHARMACOLOGY BULLETIN

VOL 51 No. 1

Articles in This Issue

ORIGINAL RESEARCH

Going Virtual During a Pandemic: An Academic Psychiatry Department’s Experience with Telepsychiatry

Background: The novel coronavirus pandemic (COVID-19) led healthcare providers, including mental health providers, across the U.S. to swiftly shift to telemedicine. Objectives: This shift gave our Department of Psychiatry a chance to better understand key...
ORIGINAL RESEARCH

Impact of the Omics-Based Biomarkers on the Fluvoxamine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder

Introduction: Fluvoxamine is commonly administered to patients with recurrent depressive disorder. Some of these patients do not show adequate response to the therapy with fluvoxamine, whereas many of them experience dose-dependent adverse drug reactions. Previous...
ORIGINAL RESEARCH

Evaluation of Risk Factors Associated to Prescription of Benzodiazepines and its Patterns in a Cohort of Patients from Mental Health: A Real World Study in Spain

Purpose: we aimed 1) to evaluate the risk factors associated to the benzodiazepines intake; 2) to assess the impact about the use of long acting injectables antipsychotics (LAIs); 3) to assess the risk in severe...
REVIEW ARTICLE

Adverse Effects of Recreational and Medical Cannabis

Purpose of Review: This comprehensive review discusses the adverse effects known today about marijuana, for either medical or recreational use. It reviews the role of cannabis in the treatment of chronic pain, cognitive and neurological...